[REGN] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -1.65%
YoY- 50.20%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 1,828,200 1,711,800 1,511,485 1,318,991 1,200,849 869,612 625,740 19.54%
PBT 668,600 546,100 585,398 432,289 330,151 276,523 175,263 24.97%
Tax 44,000 85,000 107,418 183,358 164,415 200,502 109,820 -14.12%
NP 624,600 461,100 477,980 248,931 165,736 76,021 65,443 45.59%
Tax Rate -6.58% -15.56% -18.35% -42.42% -49.80% -72.51% -62.66% -
Total Cost 1,203,600 1,250,700 1,033,505 1,070,060 1,035,113 793,591 560,297 13.57%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 34.16 26.94 31.62 18.87 13.80 8.74 10.46 21.78%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS 5.69 4.23 4.44 2.36 1.74 0.74 0.69 42.09%
EPS Diluted 5.43 3.99 4.16 2.16 1.59 0.66 0.61 43.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.